Nomura Holdings
CDLX icon

Nomura Holdings’s Cardlytics CDLX Stock Holding History

Nomura Holdings’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,240
Closed -$1.05M – 1782
2024
Q1 		$1.05M Hold
7,240
– – ﹤0.01% 1085
2023
Q4 		$667K Buy
+7,240
New +$736K ﹤0.01% 1283

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings's CDLX Position: Q2 2024 in Review

Nomura Holdings sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 3,104 shares — an estimated $450K sold.

Nomura Holdings first reported a position in CDLX in Q1 2021 and held it in 7 quarters. The position peaked at $6.01M in Q1 2021. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.

  • Nomura Holdings reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
  • Nomura Holdings sold 3,104 Cardlytics shares in Q2 2024, an estimated $450K.
  • Nomura Holdings first reported a position in Cardlytics in Q1 2021 and held it in 7 quarters.
  • Nomura Holdings's Cardlytics position peaked at $6.01M in Q1 2021.
  • 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.

Based on Nomura Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.